These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6017055)

  • 1. Control of morning stiffness in rheumatoid arthritis by high salicylate dosage. Preliminary report.
    Kendall PH; Cahill WJ
    Ann Phys Med; 1967 Feb; 9(1):19-21. PubMed ID: 6017055
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of a non-acetylated salicylate, choline magnesium trisalicylate, in the treatment of rheumatoid arthritis.
    Rothwell KG
    J Int Med Res; 1983; 11(6):343-8. PubMed ID: 6360749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate kinetics and dosage rationale.
    Med J Aust; 1972 Sep; 2(13):696. PubMed ID: 5084966
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparable serum salicylate concentrations from choline magnesium trisalicylate, aspirin, and buffered aspirin in rheumatoid arthritis.
    Binus MH; Lyon JA; Nicholas JL
    Arthritis Rheum; 1982 Apr; 25(4):464-6. PubMed ID: 7073776
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.
    Boardman PL; Hart FD
    Br Med J; 1967 Nov; 4(5574):264-8. PubMed ID: 4861386
    [No Abstract]   [Full Text] [Related]  

  • 6. Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis. Comparison of two dosage schedules of choline magnesium trisalicylate.
    Cassell S; Furst D; Dromgoole S; Paulus H
    Arthritis Rheum; 1979 Apr; 22(4):384-8. PubMed ID: 426883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Brick DL; Corrigan AB
    Med J Aust; 1970 Aug; 2(8):382-3. PubMed ID: 5457655
    [No Abstract]   [Full Text] [Related]  

  • 8. Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations.
    Gibson RG; Gibson SL; MacNeill AD; Gray GH; Dick WC; Buchanan WW
    Br J Clin Pharmacol; 1978 Nov; 6(5):391-5. PubMed ID: 365205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure to recognize efficacious treatments: a history of salicylate therapy in rheumatoid arthritis.
    Goodwin JS; Goodwin JM
    Perspect Biol Med; 1981; 25(1):78-92. PubMed ID: 7038619
    [No Abstract]   [Full Text] [Related]  

  • 11. [The presence of salicylate and its metabolites in the joint exudates of subjects with chronic arthritis treated with salicylate].
    Arata L; D'Avino R; Iacovoni P; Pecora P
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):56-8. PubMed ID: 5419766
    [No Abstract]   [Full Text] [Related]  

  • 12. [Copper salicylate in rheumatoid arthritis and rheumatism--like degenerative diseases].
    Hangarter W
    Med Welt; 1980 Nov; 31(45):1625-8. PubMed ID: 6969838
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Urich AW; Goatcher PM
    Med J Aust; 1970 Oct; 2(14):653-4. PubMed ID: 5477813
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis.
    DiPerri T; Auteri A; Fumagalli M; Gandini R; Giordano A; Giordano M; Scaricabarozzi I; Vaiani G; Vatti M
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):443-7. PubMed ID: 3308719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylate therapy in rheumatoid arthritis.
    Bayles TB
    Med Clin North Am; 1968 May; 52(3):703-6. PubMed ID: 5653943
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis.
    Sperryn PN; Hamilton EB; Parsons V
    Ann Rheum Dis; 1973 Mar; 32(2):157-61. PubMed ID: 4571392
    [No Abstract]   [Full Text] [Related]  

  • 17. Salicylate hepatotoxicity in rheumatoid arthritis.
    Mastaglia GL
    Med J Aust; 1980 Sep; 2(6):341. PubMed ID: 7421712
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 19. Unbound plasma salicylate concentration in rheumatoid arthritis patients.
    Gurwich EL; Raees SM; Skosey J; Niazi S
    Br J Rheumatol; 1984 Feb; 23(1):66-73. PubMed ID: 6697076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis.
    Blechman WJ; Lechner BL
    Rheumatol Rehabil; 1979 May; 18(2):119-24. PubMed ID: 377449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.